Viking Global Investors — BMRN

How Viking Global Investors's position in Biomarin Pharmaceutical Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held

2

First reported

Q4 2025

Latest value

$398,936,730

Latest weight

1.1%

Peak weight

1.1%

Shares since first

+17%

Position Trend

Shares, value, and weight from first report to latest report.

Viking Global Investors first reported 6,036,936 shares in Q4 2025 and most recently reported 7,062,077 shares in Q1 2026. Portfolio weight peaked at 1.1% in Q1 2026; the low reported weight was 1% in Q4 2025.

Since the first report, shares are +17% and reported value is +11.2%. Latest move: ADD